Get started
Author

Milad Peer-Firozjaei

Observed names: Milad Peer Firouzjaei, Milad Peer- Firozjaei, Milad Peer-firouzjaei
ORCID: 0000-0003-1490-9090
Observed ORCID: 0000-0003-1490-9090
OpenAlex ID: A5010859838
Bragg peak characteristics of proton beams within therapeutic energy range and the comparison of stopping power using the GATE Monte Carlo simulation and the NIST data
2019 · Shiva Zarifi, Hadi Taleshi Ahangari, et al. · Journal of Radiotherapy in Practice · 12
Implementation of dose point kernel (DPK) for dose optimization of 177Lu/90Y cocktail radionuclides in internal dosimetry
2021 · Milad Peer-Firozjaei, Mohammad Ali Tajik-Mansoury, et al. · Applied Radiation and Isotopes · 8
Optimized cocktail of 90Y/177Lu for radionuclide therapy of neuroendocrine tumors of various sizes: a simulation study
2022 · Milad Peer-Firozjaei, Mohammad Ali Tajik-Mansoury, et al. · Nuclear Medicine Communications · 4
FAP-Targeted Theranostics in Advanced Sarcoma: A Pilot Study of ⁶⁸Ga-FAPI-46 Imaging and ¹⁷⁷Lu-FAPI-2286 Therapy
2026 · Narges Jokar, Malik E. Juweid, et al. · Clinical Nuclear Medicine · 2
Preliminary Evaluation of 225Ac/177Lu-DOTATATE PRRT in Progressive Meningiomas
2026 · Reza Nemati, Malik E. Juweid, et al. · Clinical Nuclear Medicine · 1
https://jbpe.sums.ac.ir/article_47495.html
2021 · Milad Peer-Firozjaei · Journal of Biomedical Physics and Engineering · 1
PDF
Cycle-dependent variation of tumor absorbed dose rates in 177 Lu-DOTATATE therapies
2026 · Ali Shabestani Monfared, Milad Peer-Firozjaei, et al. · Biomedical Physics & Engineering Express
PDF
Assessment Relation of Myocardial Detector Counts and Administered Activity of 99mTc-SestaMIBI in MPI: The Effects of Body Weight, BMI, and Gender
2021 · Mohammad Ali Tajik-Mansoury, Mahdi Mazinani, et al. · Current Radiopharmaceuticals
Works count: 8
Citation count: 28
H-index: 3
I10-index: 1
Year
Topic
Type